MedStar Health Blog

This article was written by D. Max Smith, PharmD, BCPS.   New pharmacogenetic research answers questions about genetics and dosing of the breast cancer drug ribociclib and opens more discus...

Published in the New England Journal of Medicine, our team’s research identified seven strategies to support antiracist documentation policies and improve equity in clinical encounters.   Documen...

Social determinants of health, implicit bias, and other factors impact the health of people from disadvantaged groups. Technology and policy changes can advance equity efforts. Despite nearly 40 ye...

A new NIH-funded study will explore whether a wearable device can provide better functional recovery data after surgery for distal radius fracture.   Fractures of the wrist are very common. Yet ...

This article was written by Hannah Arem, PhD, and Claire Starling, MPH.   Our research, published in JAMA Network Open, finds significant clinical improvements in insomnia symptoms among patient...

MedStar Health was the first and among the most prominent U.S. enrollers of participants in this important global Phase III clinical trial of a new drug to treat transthyretin amyloidosis with cardio...